Corona

Novartis Establishes $5M US COVID-19 Community Response Fund

Funding and in-kind donations to support local initiatives and communities in the US impacted by the outbreak

In response to the COVID-19 pandemic in the US, Novartis and the Novartis US Foundation have established a US COVID-19 Community Response Fund. The fund will provide cash and in-kind donations totalling USD 5 million for immediate response and recovery efforts related to the pandemic.

“COVID-19 has profoundly impacted the lives of Americans in many unprecedented ways. As a leading medicines company, we understand the public health implications of this pandemic and must do our part to support organizations that are in the best position to provide services to people in need,” said Tom Kendris, US country president, Novartis Corporation and chairman, board of trustees, Novartis US Foundation. “This latest commitment is just one of many Novartis has made to help fight COVID-19 globally. From donations of hydroxychloroquine, monetary funds and equipment donations, to R&D programs and collaborations, we are humbled and pleased to offer financial support as well as scientific expertise.”

In addition to the aforementioned grants to the Commons Project, Americares and Direct Relief, the Novartis US Foundation will provide grants upwards of $100,000 through the US COVID-19 Community Response Fund, which will accept proposals for programs addressing the following:

  • Strengthening local and national healthcare infrastructure to meet increased demand and protect frontline healthworkers
  • Establishing digital platforms for COVID-19 related data collection, remote delivery of healthcare and effective dissemination of important public health information
  • Creating or enhancing new community health programs specific to the pandemic response;

To apply to the Novartis US COVID-19 Community Response Fund, please visit novartis.us/coronavirus.

To learn more about the Commons Project COVIDCheck digital app, as well as Americares and Direct Relief’s support on safety net clinics, please visit the organizations websites at:

In addition to this commitment to support external efforts around COVID-19, the company is also committed to doing our part to help slow the spread of the disease and has issued an update requesting that all non-essential US-based associates work from home starting March 16 until at least May 1, 2020.

“At Novartis we recognize the implications COVID-19 could have on the patients we serve and the healthcare providers we support,” Tom Kendris added. “We have implemented a number of solutions to help ease the burden that many may be experiencing during this time, including enhancing virtual support in our patient and physician call centers and expediting patient access requests.”

To access more business news, visit NJB News Now.

Related Articles: